Total planned funding: $277,029,203
Allocations
Countries/Regions
Eswatini | $277,029,203 |
Organizational Types
Private Contractor | $72,682,180 |
University | $57,621,828 |
Unknown | $45,792,322 |
NGO | $41,555,704 |
Own Agency | $35,225,429 |
Host Country Government Agency | $10,952,398 |
FBO | $10,806,488 |
Other USG Agency | $1,122,854 |
Multi-lateral Agency | $680,000 |
Implementing Agency | $590,000 |
Program Areas
Care | $81,256,076 |
Treatment | $73,740,925 |
Prevention | $50,473,325 |
Governance and Systems | $29,024,057 |
Management and Operations | $21,651,380 |
Testing | $20,883,440 |
Budget Codes
HTXS: Treatment: Adult Treatment | $62,415,290 |
HBHC: Care: Adult Care and Support | $32,440,079 |
HKID: Care: Orphans and Vulnerable Children | $29,684,130 |
HVMS: Management and Operations | $21,651,380 |
HVCT: Testing: HIV Testing and Counseling | $20,883,440 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,461,758 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,508,945 |
HVTB: Care: TB/HIV | $13,007,003 |
OHSS: Health Systems Strengthening | $12,666,770 |
HVSI: Strategic Information | $11,554,651 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,957,189 |
PDTX: Treatment: Pediatric Treatment | $7,108,351 |
PDCS: Care: Pediatric Care and Support | $6,124,864 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,695,433 |
HLAB: Laboratory Infrastructure | $4,802,636 |
HTXD: Treatment: ARV Drugs | $4,217,284 |
HMBL: Biomedical Prevention: Blood Safety | $850,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$48,338,452
Countries/Regions
Pact, Inc.:
$34,597,780
Countries/Regions
Not Available:
$27,482,456
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions